[go: up one dir, main page]

ES2145388T3 - Ensayos de antigenos lipopolisacaridos. - Google Patents

Ensayos de antigenos lipopolisacaridos.

Info

Publication number
ES2145388T3
ES2145388T3 ES96305901T ES96305901T ES2145388T3 ES 2145388 T3 ES2145388 T3 ES 2145388T3 ES 96305901 T ES96305901 T ES 96305901T ES 96305901 T ES96305901 T ES 96305901T ES 2145388 T3 ES2145388 T3 ES 2145388T3
Authority
ES
Spain
Prior art keywords
antigens
lipopolisaccharid
tests
chapso
chaps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96305901T
Other languages
English (en)
Inventor
Jeanette Elizabeth Brid Menton
Paul Raymond Sheard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unilever NV
Original Assignee
Unilever NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever NV filed Critical Unilever NV
Application granted granted Critical
Publication of ES2145388T3 publication Critical patent/ES2145388T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
    • Y10T436/25125—Digestion or removing interfering materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE PRESENTA UNA EXTRACCION MEJORADA Y UN ENSAYO DE ANTIGENOS DE LIPOPOLISACARIDOS SOLUBILIZADOS A PARTIR DE BACTERIAS TALES COMO LA "CHLAMYDIA" MEDIANTE EL USO DE UN NEUTRALIZADOR QUE CONTIENE UN POLISACARIDO ANIONICO, ESPECIALMENTE HEPARINA Y UN AGENTE DE SUPERFICIE ACTIVA, ESPECIALMENTE CHAPS O CHAPSO.
ES96305901T 1995-09-14 1996-08-12 Ensayos de antigenos lipopolisacaridos. Expired - Lifetime ES2145388T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95306506 1995-09-14

Publications (1)

Publication Number Publication Date
ES2145388T3 true ES2145388T3 (es) 2000-07-01

Family

ID=8221332

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96305901T Expired - Lifetime ES2145388T3 (es) 1995-09-14 1996-08-12 Ensayos de antigenos lipopolisacaridos.

Country Status (5)

Country Link
US (1) US6159703A (es)
JP (1) JP3534952B2 (es)
AT (1) ATE190725T1 (es)
DE (1) DE69607095T2 (es)
ES (1) ES2145388T3 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018634A1 (en) * 2002-07-29 2004-01-29 Kiamars Hajizadeh Sample-collection and preparation device and method
US7585641B2 (en) * 2003-01-21 2009-09-08 Agdia, Inc. Immunoassay and method of use
US7815854B2 (en) 2004-04-30 2010-10-19 Kimberly-Clark Worldwide, Inc. Electroluminescent illumination source for optical detection systems
US7796266B2 (en) 2004-04-30 2010-09-14 Kimberly-Clark Worldwide, Inc. Optical detection system using electromagnetic radiation to detect presence or quantity of analyte
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US20060217443A1 (en) * 2005-03-28 2006-09-28 Kimberly-Clark Worldwide, Inc. Method for preventing and/or treating vaginal and vulval infections
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
JP6096586B2 (ja) * 2013-05-10 2017-03-15 デンカ生研株式会社 蛍光色素で標識された可視域着色不溶性担体粒子の調製とそれを用いたイムノアッセイ法
DE102014220090B3 (de) * 2014-10-02 2015-10-08 Abf Diagnostics Gmbh Probennahmevorrichtung mit Probenaufarbeitungsfunktion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4760131A (en) * 1986-04-23 1988-07-26 Collagen Corporation Wound-healing composition
US4914041A (en) * 1988-02-12 1990-04-03 Beckman Instruments, Inc. Reagent and method for detecting rheumatoid factor
US4916057A (en) * 1988-02-29 1990-04-10 Kallestad Diagnostics, Inc. Chlamydia assay employing base treatment
GB8820375D0 (en) * 1988-08-26 1988-09-28 Boots Celltech Diagnostics Assay
ATE108557T1 (de) * 1989-04-14 1994-07-15 Unilever Nv Extraktionsverfahren.
JP3524120B2 (ja) * 1992-05-08 2004-05-10 生化学工業株式会社 前処理剤、前処理方法、前処理された試料による測定法、測定用キット及び試料の判定方法
US5302405A (en) * 1992-08-31 1994-04-12 Campbell Soup Company Method for removing cholesterol and fat from egg yolk by chelation and reduced-cholesterol egg product
EP0608546A3 (en) * 1992-12-22 1995-09-27 Takeda Chemical Industries Ltd Glia activating factor (gaf), antibodies against it and their uses.

Also Published As

Publication number Publication date
DE69607095T2 (de) 2000-11-02
DE69607095D1 (de) 2000-04-20
JPH09127110A (ja) 1997-05-16
ATE190725T1 (de) 2000-04-15
US6159703A (en) 2000-12-12
JP3534952B2 (ja) 2004-06-07

Similar Documents

Publication Publication Date Title
ES2145388T3 (es) Ensayos de antigenos lipopolisacaridos.
DE69840025D1 (de) Assoziierter antworten
ES2124668B1 (es) "nuevosl-arilpirazoles con propiedades plaguicidas.
TR199701252T1 (xx) Bir saponin ve bir sterol i�eren a��lar.
DE69612848D1 (de) Bioabbaubare alkylenoxyd-lakton copolymer
CA2226353A1 (en) Improvements relating to locating devices
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
HUP9802199A1 (hu) Poliszacharid antigén-vivőprotein konjugátumot és szabad vivőproteint tartalmazó oltóanyag és alkalmazása
DE59603145D1 (de) Vorrichtung zur Zugabe von Reinigungsmitteln, insbesondere für Geschirrspülmaschinen
DE69610835D1 (de) Elastischer puffer
EP0784265A3 (en) Method and system of dynamically moving objects between heterogeneous execution environments
ES2090248T3 (es) Metodo para analizar un anticuerpo contra chlamydia trachomatis y preparacion de diagnostico para la infeccion de chlamydia trachomatis.
KR920017934A (ko) 엘리베이터 카내의 소음과 진동을 최소화시키는 장치
HUP9801572A2 (hu) Chlamydia-vakcinák
NO954387D0 (no) Elektrokjemiluminescensfremgangsmåte
ES2186807T3 (es) Inhibidores de trombina.
ES2056378T3 (es) Procedimiento de extraccion.
ATE197645T1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
ES2149448T3 (es) Agentes terapeuticos y analiticos.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
ES2196802T3 (es) Lactatos de citronelilo y/o de dihidrocitronelilo, su preparacion y su utilizacion.
ATE269400T1 (de) Katabolisch nicht reprimierte substrat- beschränkte hefe-stämme
ATE237000T1 (de) Verfahren zum biologischen abbau von polyorganosiloxanen durch einen mikroskopischen pilz und aufspürungsmethode
ATE170292T1 (de) Nachweis von antibiotika
NL1001636A1 (nl) Entinrichting.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 763737

Country of ref document: ES